Martin and Harris Laboratories Limited
- Current price
- ₹875.00 Per share
- Market cap
- ₹350 Cr Total valuation
- P/E ratio
- 5.27 Price to earnings
- Sector
- Healthcare & Pharmaceuticals Industry
About Martin and Harris Laboratories Limited
Martin and Harris Laboratories Limited operates in the Healthcare & Pharmaceuticals sector. Its shares are not listed on stock exchanges like NSE or BSE and are traded through private transactions. On InvestShare, Martin and Harris Laboratories Limited shares are currently priced at ₹875.00 per share.
Shares in private companies can offer exposure before a potential IPO. They carry higher risk than listed stocks, so proper research and a long-term outlook are important.
Martin and Harris Laboratories Limited share FAQs
What is the Martin and Harris Laboratories Limited share price today?
The current Martin and Harris Laboratories Limited share price on InvestShare is ₹875.00 per share. Private-market share prices are indicative and may change.
How can I buy Martin and Harris Laboratories Limited shares?
Complete a simple KYC on InvestShare with your PAN, Aadhaar and demat account details, then place a buy request for Martin and Harris Laboratories Limited. After confirmation and settlement, the shares are transferred to your demat account through an off-market transaction.
Is a demat account required to buy Martin and Harris Laboratories Limited shares?
Yes, a demat account is required to hold Martin and Harris Laboratories Limited shares. The shares are credited to your demat account through an off-market transfer.
Key data & fundamentals
About Martin and Harris Laboratories Limited
iMartin & Harris Laboratories Ltd incorporated in 1996 at Gurgaon, Haryana is a part of “Apeejay Group”, India’s oldest and largest business conglomerates.
iiMartin & Harris Laboratories Ltd is engaged in manufacturing of pharmaceuticals, medicinal chemical & botanical products. Following is the revenue contribution from different business verticals. Pharma business = 52% Derivative and Investment business = 48%
iiiThe Company has been awarded “Best Innovative in process & formulation development” by the director-general of health service, ministry of the health & family welfare, Government of India.
- Indicative price
- ₹875.00
- Lot size
- 100
- 52 week high
- ₹950
- 52 week low
- ₹850
- Market cap
- ₹350 Cr
- No. of shares
- 39,96,040
- P/E ratio
- 5.27
- P/B ratio
- 0.49
- ROE
- 9.39 %
- Book value
- ₹1,794.25
- Face value
- ₹10
- ISIN
- INE03VV01015
- PAN
- AABCM0832A
Indicative price history
Financial statements
- Revenue · FY25
- 107.4 ₹ Cr ▼Down26%
- EBITDA · FY25
- 8.4 ₹ Cr ▼Down68%
- Profit before tax · FY25
- 83 ₹ Cr ▲Up51%
- Net profit (PAT) · FY25
- 66.4 ₹ Cr ▲Up66%
- Operating margin · FY25
- 7.82% ▼Down56%
- EPS · FY25
- ₹166.42 ▲Up66%
| Particulars | FY22 | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|---|
| Revenue | 186 | 205 | 146 | 107.4 | ▼Down26% |
| EBITDA | 70 | 72 | 26 | 8.4 | ▼Down68% |
| OPM (%) | 37.63 | 35.12 | 17.81 | 7.82 | ▼Down56% |
| PBT | 93 | 92 | 55 | 83 | ▲Up51% |
| PAT | 70 | 68 | 40 | 66.4 | ▲Up66% |
| EPS (₹) | 175.44 | 170.43 | 100.25 | 166.42 | ▲Up66% |
| Particulars | FY22 | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|---|
| Share capital | 3.99 | 3.99 | 3.99 | 3.99 | — |
| Reserves | 523 | 589 | 628 | 703 | ▲Up12% |
| Borrowings | 5 | 4 | 8 | 13 | ▲Up63% |
| Total assets | 543 | 615 | 662 | 749 | ▲Up13% |
| Total liabilities | 543 | 615 | 662 | 749 | ▲Up13% |
| Investments | 373 | 62 | 70 | 19 | ▼Down73% |
| Particulars | FY22 | FY23 | FY24 | FY25 | YoY |
|---|---|---|---|---|---|
| CFO | 152 | -344 | 19 | 273.6 | ▲Up999+% |
| CF investing | -132 | 325.4 | -21 | -274 | ▼Down999+% |
| CF financing | -0.7 | -1.94 | 1 | 3.1 | ▲Up210% |
| Net cash | 19.3 | -20.54 | -1 | 2.7 | ▲Up370% |
| Cash at end | 21.6 | 0.78 | -0.2 | 2.95 | ▲Up999+% |